Stay updated on Tirzepatide in CKD and Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.

Latest updates to the Tirzepatide in CKD and Obesity Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoChange DetectedThe date has been updated from February 25, 2025, to April 20, 2025.SummaryDifference0.6%
- Check23 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 25, 2025.SummaryDifference0.6%
- Check66 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Tirzepatide in CKD and Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.